ClinicaliQ Trial Snapshot
- A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet) — Active Not Recruiting • Phase III • Rheumatology • NCT06095102.
- New drug JNJ-77242113 tested for treating psoriasis in difficult-to-treat areas like scalp, genitals, palms and soles.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/or palms of the hands and the soles of the feet). Conditions: Plaque Psoriasis Interventions: JNJ-77242113, Placebo Lead Sponsor: Janssen Research & Development, LLC Planned Enrollment: 311 participants